已发表论文：（*为通讯作者） (1) Bixing Zhao #, Kun Ke #, Yingchao Wang #, Fei Wang #, Yingjun Shi, Xiaoyuan Zheng, Xiaoyu Yang, Xiaolong Liu（*）, Jingfeng Liu（*）. HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis. Signal Transduction and Targeted Therapy. 2020 Jul 7;5(1):118 (2) Yang Li #, Jinyan Lin #, Peiyuan Wang, Qiang Luo, Fukai Zhu, Yun Zhang, Zhenqing Hou, Xiaolong Liu（*）, Jingfeng Liu（*）. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy. Nano-micro Letters. 2020 Sep 14;12(1):182 (3) Xiaoyan Wang, Ming Wu, Xiaolong Zhang, Feida Li, Yongyi Zeng, Xinyi Lin（*）, Xiaolong Liu（*）, Jingfeng Liu（*）. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. Journal of Nanobiotechnology. 2021 Jul 8;19(1):204 (4) Da Zhang,Ziguo Lin, Ming Wu, Zhixiong Cai, Youshi Zheng, Lei He,Zhenli Li,Jie Zhou,Liqin Sun, Geng Chen, Yongyi Zeng, Juan Li, Jingfeng Liu（*）, Huanghao Yang（*）,Xiaolong Liu（*）. Cytosolic Delivery of Thiolated Neoantigen Nano-Vaccine Combined with Immune Checkpoint Blockade to Boost Anti-Cancer T Cell Immunity. Advanced Science. 2021 Mar; 8(6): 2003504. (5) Peiyuan Wang, Lianli Peng, Jinyan Lin, Yang Li, Qiang Luo, Suhua Jiang, Haina Tian, Yun Zhang, Xiaolong Liu（*）, Jingfeng Liu（*）. Enzyme hybrid virus-like hollow mesoporous CuO adhesive hydrogel spray through glucose-activated cascade reaction to efficiently promote diabetic wound healing. Chemical Engineering Journal. 2021, Volume 415,128901 (6) Lei Chen, Ghassan K. Abou-Alfa, Bo Zheng, Jing-Feng Liu, Jian Bai, Lu-Tao Du, Yun-Song Qian, Rong Fan, Xiao-Long Liu, Lin Wu（*）, Jin-Lin Hou（*），Hong-Yang Wang（*），The PreCar Team. Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients. Cell Research. 2021 May;31(5):589-592
授权发明专利： (1) 发明人: 刘景丰，刘小龙，黄爱民，张达. 用于肝癌多模态影像和光热治疗的多功能纳米探针及应用. 授权号：ZL201310695697.4, 授权日期: 2016/06 (2) 发明人: 刘景丰，刘小龙，韦学勇，黄爱民，王庆堂，曾永毅. 基于抗体修饰ZnSe纳米晶检测肝癌标志物GPC3的试剂盒. 授权号：ZL201410109381.7, 授权日期: 2016/08 (3) 发明人: 刘景丰，曾永毅，刘小龙，张晓龙，郑爱仙，廖乃顺. 一种检测galectin-4的荧光酶联免疫分析方法. 授权号：ZL201610539941.1, 授权日期: 2018/03 (4) 发明人: 刘景丰, 刘小龙, 张晓龙, 廖乃顺, 郑爱仙, 曾永毅. 一种细胞凋亡双色检测和成像探针及其应用. 授权号：ZL201710432782.X, 授权日期: 2019/09 (5) 发明人: 刘景丰, 刘小龙, 吴名, 曾永毅. 一种具有光响应降解的阿霉素前体化合物及其制备与应用. 授权号：ZL201610539941.1, 授权日期: 2019/12 (6) 发明人: 刘景丰, 刘小龙, 林心怡, 曾永毅. 一种光响应性氧化硅纳米载体及其制备方法. 授权号：ZL201710655234.3, 授权日期: 2020/06 (7) 发明人: 刘景丰, 刘小龙, 邢晓华, 孙颖. 血清CA2蛋白在制备肝癌诊断或预后评估试剂盒的应用. 授权号：ZL201711297274.1, 授权日期: 2020/07 (8) 发明人: 刘景丰，刘小龙，郑友世，张达，曾永毅. 一种增强NK细胞对肿瘤细胞靶向杀伤力的培养方法. 授权号：ZL202010353458.0, 授权日期: 44869 (9) 发明人: 刘景丰，黄爱民，刘小龙，蔡志雄，黄新辉. Galectin4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用. 授权号：ZL201310428032.7, 授权日期: 42018 (10) 发明人: 刘景丰,郭鹏飞,林昭旺,傅俊,丁宗仁,陈振伟:陈传椿，李保晟.张浩海. 肝脏CT、MRI多期增强检查图像的配准方法. 授权号：ZL202110096850.6, 授权日期: 44985 |
